PulseAugur
EN
LIVE 21:54:07
ENTITY MTS-128

MTS-128

PulseAugur coverage of MTS-128 — every cluster mentioning MTS-128 across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-07-02 product_launch Metis TechBio's AI-powered cancer drug candidate, MTS-128, is being developed globally by Boulevard Bio. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_121904 ·

    China's AI drug design firms secure $75B in deals amid US scrutiny

    Chinese AI-driven drug design companies are experiencing a surge in global dealmaking, with out-licensing deals valued at $75 billion in the first five months of 2026. This represents a significant increase from pre-202…